openPR Logo
Press release

Acute Social Anxiety Disorder Market Forecast 2032: Epidemiology, Drugs, Clinical Trials, Companies & Growth Analysis Report - Segmented By Therapies, Countries, by DelveInsight | Vistagen Therapeutics, Bionomics, Pfizer, GSK plc, Lundbeck A/S, Eli Lily

02-05-2024 12:50 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Acute Social Anxiety Disorder Market

Acute Social Anxiety Disorder Market

(Albany, USA) DelveInsight's "Acute Social Anxiety Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Acute Social Anxiety Disorder, historical and forecasted epidemiology as well as the Acute Social Anxiety Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Download the report to know more about Acute Social Anxiety Disorder market trends @ Acute Social Anxiety Disorder market insight - https://www.delveinsight.com/report-store/acute-social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key highlights of Acute Social Anxiety Disorder market report are:
• According to DelveInsight, Acute Social Anxiety Disorder market size is anticipated to grow at a decent CAGR during the study period, 2019-2032.
• The increase in Acute Social Anxiety Disorder market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM.
• Key Acute Social Anxiety Disorder Companies working in the market are Vistagen Therapeutics, Bionomics and Pfizer Inc., GSK plc, Lundbeck A/S, Eli Lily, Merck, AstraZeneca, Forest Laboratories, Sanofi Aventis, Johnson and Johnson, and others.
• Emerging Acute Social Anxiety Disorder therapies fuelling the market are PH94B, BNC210 and others.
• On 22 June 2022, The PALISADE-1 Phase 3 Clinical Study of PH94B for the Acute Treatment of Social Anxiety Disorder has been announced by VistaGen
• On 19 April 2022, as an intranasal therapy for severe anxiety disorders, aloradine is available from Pherin Pharmaceutical
• On 5 April 2022, Tandospirone is a partial agonist at serotonin1A receptors with anxiolytic action that was created by Sumitomo Pharma
• According to National Institute of Health and Care Excellence (NICE), the lifetime prevalence of Social Anxiety disorder is 12% in UK population.

Acute Social Anxiety Disorder Overview:
Social Anxiety disorder (also called Social Phobia; SAD) is the most common mental health condition which causes extreme fear in social settings, and an intense, persistent fear of being watched and judged by others. People with social anxiety disorder have trouble talking to people, meeting new people, attend social gatherings and can also affect day-to-day activities.

Download the report to understand which factors are driving Acute Social Anxiety Disorder epidemiology trends @ Acute Social Anxiety Disorder Epidemiological Insights- https://www.delveinsight.com/report-store/acute-social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key benefits of the Acute Social Anxiety Disorder Market report:
• Acute Social Anxiety Disorder market report covers a descriptive overview and comprehensive insight of the Acute Social Anxiety Disorder Epidemiology and Acute Social Anxiety Disorder market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
• The Acute Social Anxiety Disorder market report provides insights on the current and emerging therapies.
• Acute Social Anxiety Disorder market report provides a global historical and forecasted market covering drug outreach in 7MM.
• The Acute Social Anxiety Disorder market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Acute Social Anxiety Disorder market.

Acute Social Anxiety Disorder Epidemiology
The Acute Social Anxiety Disorder epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The Acute Social Anxiety Disorder epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Acute Social Anxiety Disorder Epidemiology Segmentation:
The Acute Social Anxiety Disorder market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Acute Social Anxiety Disorder
• Prevalent Cases of Acute Social Anxiety Disorder by severity
• Gender-specific Prevalence of Acute Social Anxiety Disorder
• Diagnosed Cases of Acute Social Anxiety Disorder

Download free sample report to know more about recent developments in Acute Social Anxiety Disorder treatment market, visit @ Acute Social Anxiety Disorder Clinical Trials - https://www.delveinsight.com/sample-request/acute-social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Acute Social Anxiety Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Acute Social Anxiety Disorder market or expected to get launched during the study period. The analysis covers Acute Social Anxiety Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Acute Social Anxiety Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Acute Social Anxiety Disorder market share @ Acute Social Anxiety Disorder market forecast- https://www.delveinsight.com/sample-request/acute-social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Acute Social Anxiety Disorder Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Acute Social Anxiety Disorder Companies: Vistagen Therapeutics, Bionomics and others.
• Key Acute Social Anxiety Disorder Therapies: PH94B, BNC210 and others.
• Acute Social Anxiety Disorder Therapeutic Assessment: Acute Social Anxiety Disorder current marketed and Acute Social Anxiety Disorder emerging therapies
• Acute Social Anxiety Disorder Market Dynamics: Acute Social Anxiety Disorder market drivers and Acute Social Anxiety Disorder market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Acute Social Anxiety Disorder Unmet Needs, KOL's views, Analyst's views, Acute Social Anxiety Disorder Market Access and Reimbursement

Table of Contents
1. Acute Social Anxiety Disorder Market Report Introduction
2. Executive Summary for Acute Social Anxiety Disorder
3. SWOT analysis of Acute Social Anxiety Disorder
4. Acute Social Anxiety Disorder Patient Share (%) Overview at a Glance
5. Acute Social Anxiety Disorder Market Overview at a Glance
6. Acute Social Anxiety Disorder Disease Background and Overview
7. Acute Social Anxiety Disorder Epidemiology and Patient Population
8. Country-Specific Patient Population of Acute Social Anxiety Disorder
9. Acute Social Anxiety Disorder Current Treatment and Medical Practices
10. Acute Social Anxiety Disorder Unmet Needs
11. Acute Social Anxiety Disorder Emerging Therapies
12. Acute Social Anxiety Disorder Market Outlook
13. Country-Wise Acute Social Anxiety Disorder Market Analysis (2019-2032)
14. Acute Social Anxiety Disorder Market Access and Reimbursement of Therapies
15. Acute Social Anxiety Disorder Market Drivers
16. Acute Social Anxiety Disorder Market Barriers
17. Acute Social Anxiety Disorder Appendix
18. Acute Social Anxiety Disorder Report Methodology
19. DelveInsight Capabilities
20. Disclaimer

To know more about Acute Social Anxiety Disorder treatment, visit @ Acute Social Anxiety Disorder Medications- https://www.delveinsight.com/sample-request/acute-social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• Acral Lentiginous Melanoma Market: https://www.delveinsight.com/report-store/acral-lentiginous-melanoma-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Binge Eating Disorder Market: https://www.delveinsight.com/report-store/binge-eating-disorders-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelogenous-leukemia-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
• Partial Seizure Market: https://www.delveinsight.com/report-store/partial-seizure-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
• Cluster Headache Market: https://www.delveinsight.com/report-store/cluster-headache-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Actinic Keratosis Market: https://www.delveinsight.com/report-store/actinic-keratosis-market
• Aesthetic Implants Market: https://www.delveinsight.com/report-store/aesthetic-implants-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-pipeline-insight
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Chemotherapy Induced Thrombocytopenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-thrombocytopenia-market-size
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/hyperhidrosis-market
• Ventricular Hypertrophy Market: https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-pipeline-insight
• Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/intracranial-aneurysms-market-insight
• Lewy Body Dementia Market: https://www.delveinsight.com/report-store/lewy-body-dementia-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market
• Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/relapsed-chronic-lymphocytic-leukemia-cll-market
• Ventilator Market: https://www.delveinsight.com/report-store/ventilators-market

Contact Us:
Ankit Nigam
Assistant Manager Marketing
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/consulting/conference-coverage-services

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Social Anxiety Disorder Market Forecast 2032: Epidemiology, Drugs, Clinical Trials, Companies & Growth Analysis Report - Segmented By Therapies, Countries, by DelveInsight | Vistagen Therapeutics, Bionomics, Pfizer, GSK plc, Lundbeck A/S, Eli Lily here

News-ID: 3372898 • Views:

More Releases from DelveInsight Business Research

Global General Surgery Devices Market is expected to grow at a CAGR of 6.3% by 2032 | DelveInsight
Global General Surgery Devices Market is expected to grow at a CAGR of 6.3% by 2 …
General Surgery Devices Market Overview The Global General Surgery Devices Market is projected to grow at a CAGR of 6.34% from 2025 to 2032, driven by the rising burden of chronic diseases, increasing surgical interventions, and the adoption of robotic-assisted and minimally invasive techniques. Covering instruments such as handheld tools, electrosurgical devices, laparoscopic systems, wound closure products, and disposables, these devices play a critical role in diverse procedures, including orthopedic, cardiovascular,
Intratumoral Cancer therapies Market Outlook 2034 - Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight
Intratumoral Cancer therapies Market Outlook 2034 - Clinical Trials, Market Size …
Intratumoral Cancer Market Summary Intratumoral cancer therapies involve direct delivery into tumors, enabling localized targeting with minimal damage to surrounding tissue. Within the 7MM, non-melanoma cancers represent the largest share of cases and are expected to rise at ~2% annually, while in the US, breast cancer accounts for about 30% of cases with a growing incidence rate for intratumoral therapies. Currently, IMLYGIC is the only FDA-approved intratumoral therapy for melanoma, holding
Bispecific and Trispecific Antibodies Market Projected to Experience Significant Growth by 2035, Reports DelveInsight
Bispecific and Trispecific Antibodies Market Projected to Experience Significant …
Bispecific antibodies represent an innovative class of therapies designed to address complex diseases by simultaneously binding two targets with a single molecule. Most currently approved bispecifics are for oncology, particularly multiple myeloma and diffuse large B-cell lymphoma (DLBCL). Beyond oncology, only HEMLIBRA and VABYSMO are approved for conditions such as hemophilia A, wet age-related macular degeneration, and diabetic macular edema, while KIMMTRAK is approved for uveal melanoma. The pipeline remains
Narcolepsy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Narcolepsy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Update …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Narcolepsy pipeline constitutes 10+ key companies continuously working towards developing 12+ Narcolepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Narcolepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Social

Social Media Management Market, Social Media Management Market Size, Social Medi …
The Social Media Management Market is growing rapidly as businesses increasingly rely on social platforms to engage with customers, build brand awareness, and drive digital marketing strategies. Social media management solutions help organizations streamline content creation, scheduling, analytics, and audience engagement across multiple platforms, enabling more efficient and effective campaigns. With the rise of data-driven marketing, these tools also provide valuable insights into user behavior, trends, and campaign performance. As
Introducing Waby Social - The Revolutionary Social Networking Platform
Waby Social is proud to announce the launch of its highly anticipated social networking platform, designed to revolutionize the way people interact online. With a focus on user privacy, simplicity, and seamless functionality, Waby Social promises to deliver a new standard of social media experience. Waby Social aims to address the growing concerns of privacy and security issues that have plagued the social media landscape for years. The platform is designed
Global Social Television Market by Types (Sharing Technology, Social EPG/Content …
The Global Social Television Market is expected to reach US$ XX Million by 2026, with a CAGR of XX% from 2021 to 2026, based on a newly published report. Global Social Television Market Overview Social Television Market research report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Global social television is a new form of television that is growing in popularity. Social television
Customer Relationship Management (CRM) Market Report 2018: Segmentation by Socia …
Global Customer Relationship Management (CRM) market research report provides company profile for SAP, Oracle, Salesforce.com, Amdocs, IBM and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the
Very social, but not just social media
Which channels are customers’ favourites when it comes to sharing good experiences? By: Graham Ede, Yonder Digital Group “Twice as many people tell others about bad experiences as opposed to the good ones” do you believe in this old adage? If so, you would not be alone, however, latest research commissioned by Yonder Digital Group reveals this common perception is in fact not true. A key game-changer has been the rise of
Trig Social Media announces acquisition of social-commerce.co
Trig social media AB is delighted to announce acquisition of 50.5% of www.social-commerce.co and its holding company Fusion Finance with an option to acquire the remaining 49.5% toward the end of the year. The transaction will be completed with 9 million Trig Social Media shares to be issued shortly. The price for the remaining 49.5% is performance based. Social-commerce is a gamified gig economy platform with an affiliate component that is